Dave Paterson - Canopy Growth President Canada
| CGC Stock | USD 3.87 0.03 0.77% |
President
Dave Paterson is President Canada of Canopy Growth Corp
| Address | 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8 |
| Phone | 855 558 9333 |
| Web | https://www.canopygrowth.com |
Canopy Growth Management Efficiency
The company has Return on Asset of (0.0439) % which means that on every $100 spent on assets, it lost $0.0439. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.9303) %, meaning that it generated no profit with money invested by stockholders. Canopy Growth's management efficiency ratios could be used to measure how well Canopy Growth manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.34. In addition to that, Return On Capital Employed is expected to decline to -0.33. The current year's Non Currrent Assets Other is expected to grow to about 341.8 M, whereas Total Assets are forecasted to decline to about 26 M.Similar Executives
| Found 9 records | PRESIDENT Age | ||
| Prashanth MahendraRajah | Analog Devices | 54 | |
| Jill Hazelbaker | Uber Technologies | 42 | |
| Tony West | Uber Technologies | 55 | |
| Michal Tsur | Kaltura | 50 | |
| Joseph Hassett | Analog Devices | 66 | |
| Nikki Krishnamurthy | Uber Technologies | 51 | |
| Martin Cotter | Analog Devices | 59 | |
| Andrew Shape | Software Acquisition Group | 51 | |
| Andrew Macdonald | Uber Technologies | N/A | |
Management Performance
| Return On Equity | -0.93 | ||||
| Return On Asset | -0.0439 |
Canopy Growth Corp Leadership Team
Elected by the shareholders, the Canopy Growth's board of directors comprises two types of representatives: Canopy Growth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Canopy. The board's role is to monitor Canopy Growth's management team and ensure that shareholders' interests are well served. Canopy Growth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Canopy Growth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Ware, Chief Medical Officer | ||
| Judy Hong, Interim Chief Financial Officer | ||
| Terry Yanofsky, Director | ||
| FCPA FCA, Strategic Advisor | ||
| David Klein, Chief Executive Officer, Director | ||
| Robert Hanson, Independent Director | ||
| Christelle LLB, Chief Secretary | ||
| Tara Rozalowsky, Interim Chief Product Officer | ||
| Chris Edwards, Chief Officer | ||
| Dave Paterson, President Canada | ||
| Ru Wadasinghe, Chief Information Officer | ||
| Judy Schmeling, Independent Chairman of the Board | ||
| James Sabia, Independent Director | ||
| William Newlands, Independent Director | ||
| David Lazzarato, Independent Director | ||
| Phillip Shaer, Corporate Secretary, Chief Legal Officer | ||
| Theresa Yanofsky, Independent Director | ||
| Julious Grant, Chief Commercial Officer | ||
| Jonathan Tosto, Chief Officer | ||
| Thomas IV, Senior Officer | ||
| Jenny Brewer, Chief Officer | ||
| Jason Green, Head Division | ||
| Thomas Stewart, Chief Accounting Officer, Vice President | ||
| Tyler Burns, Director Relations | ||
| Thomas Shipley, Senior Vice President and Chief Science Officer | ||
| Jimes Sabia, Director | ||
| Rade Kovacevic, Vice President - Sales and Customer Experience | ||
| Mike Lee, Chief Financial Officer, Executive Vice President | ||
| Jurgen Bickel, MD GmbH |
Canopy Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Canopy Growth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.93 | ||||
| Return On Asset | -0.0439 | ||||
| Profit Margin | (2.01) % | ||||
| Operating Margin | (0.34) % | ||||
| Current Valuation | 684.27 M | ||||
| Shares Outstanding | 105.36 M | ||||
| Shares Owned By Insiders | 0.17 % | ||||
| Shares Owned By Institutions | 8.78 % | ||||
| Number Of Shares Shorted | 10.09 M | ||||
| Price To Earning | (20.08) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Canopy Growth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Canopy Growth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Canopy Growth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Canopy Growth Corp Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Canopy Growth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Canopy Growth. If investors know Canopy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Canopy Growth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Revenue Per Share 3.315 | Quarterly Revenue Growth (0.1) | Return On Assets (0.04) | Return On Equity (0.93) |
The market value of Canopy Growth Corp is measured differently than its book value, which is the value of Canopy that is recorded on the company's balance sheet. Investors also form their own opinion of Canopy Growth's value that differs from its market value or its book value, called intrinsic value, which is Canopy Growth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Canopy Growth's market value can be influenced by many factors that don't directly affect Canopy Growth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Canopy Growth's value and its price as these two are different measures arrived at by different means. Investors typically determine if Canopy Growth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Canopy Growth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.